Guideline for chemotherapy generics to be formulated
Published: 2010-04-12 07:00:00
Updated: 2010-04-12 07:00:00
The Korea Food and Drug Administration is considering drafting a guideline for approval of oral chemotherapy generics, including Xeloda (Capecitabine), as part of effort to encourage local drug makers to market them within an earlier period.
To this end, the drug agency said its Central Pharma...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
